3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
6
Genitourinary
1
Dermatologic
1
Conditions
Melanoma
10
Penile Neoplasms
1
Neoplasm Micrometastasis
1
Mouth Neoplasms
1
Lymphatic Metastasis
1
Eccrine Porocarcinoma
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Interventions
pembrolizumab
2
Specimen Handling
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
trastuzumab deruxtecan
1
motexafin gadolinium
1
cabozantinib
1
brodalumab
1
Tomography, Optical Coherence
1
Taxes
1
Surveys and Questionnaires
1
Spectrometry, Fluorescence
1
Sentinel Lymph Node Biopsy
1
Ritonavir
1
Radiotherapy
1
Psychology, Positive
1
Pemetrexed
1
Paclitaxel
1
Optical Imaging
1
Molecular Diagnostic Techniques
1
Methods
1
Ipilimumab
1
Indinavir
1
Etoposide
1
Drug Therapy
1
Doxorubicin
1
Cyclophosphamide
1
Cisplatin
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
Sentinel Lymph Node Biopsy
×
Dermatologic
×
Clear all
NCT06666634
2024-10-30
NANOSCAN
The Netherlands Cancer Institute
Phase NA
Recruiting
29 enrolled